The impact of ageing and menopause in women with polycystic ovary syndrome

Helvaci N., YILDIZ O. B.

CLINICAL ENDOCRINOLOGY, cilt.97, sa.3, ss.371-382, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 97 Sayı: 3
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1111/cen.14558
  • Dergi Adı: CLINICAL ENDOCRINOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CAB Abstracts, EMBASE, Gender Studies Database, MEDLINE
  • Sayfa Sayıları: ss.371-382
  • Anahtar Kelimeler: cardiovascular disease, depression, diabetes, endometrial cancer, menopause, obstructive sleep apnoea, PCOS, OBSTRUCTIVE SLEEP-APNEA, INTIMA-MEDIA THICKNESS, NORMAL-WEIGHT WOMEN, FOLLOW-UP, CARDIOVASCULAR-DISEASE, POSTMENOPAUSAL WOMEN, DIABETES-MELLITUS, INCREASED RISK, REFERRAL BIAS, PCOS
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Polycystic ovary syndrome (PCOS) is a common hormonal, metabolic and reproductive disorder. Women with PCOS at reproductive age have increased risk and prevalence of prediabetes and diabetes and have multiple risk factors for cardiometabolic disease and other comorbidities such as obstructive sleep apnoea, endometrial cancer and mood disorders, which contribute to the overall health burden of the syndrome. However, little is known about the impact of PCOS on long-term health in ageing women. In this review, we aimed to give an updated overview regarding the long-term health outcomes of PCOS and their clinical implications in peri- and postmenopause. The PCOS phenotype ameliorates with ageing and limited available data suggest that there is no further deterioration in cardiometabolic profile in women with PCOS after menopause. Accordingly, the risk of cardiovascular disease in ageing women with PCOS seems to be no different from those without PCOS and lower than previously anticipated based on their risk during reproductive years. Regarding other comorbidities including sleep apnoea, mood disorders and endometrial cancer, it is difficult to determine the true risk in older women with PCOS due to the confounding factors and lack of long-term cohort studies. Large, prospective studies on community-based and well-phenotyped PCOS cohorts with extended follow-up into late menopause are needed to confirm these findings.